<PAGE>
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 28, 1997
---------------
SERACARE, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-21781 95-4343492
- --------------------------------------------------------------------------------
(State or other (Commission (I.R.S. Employer
jurisdiction of File Number) Identification
incorporation) Number)
1925 Century Park East, Suite 1970, Los Angeles, California 90067
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (310) 772-7777
-------------------
Not Applicable
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Total sequentially numbered pages in this document: 3.
<PAGE>
ITEM 5. OTHER ITEMS.
------------
On May 28, 1997, the Board of Directors of SeraCare, Inc. established an Audit
Committee consisting of:
Dr. Nelson Teng - Outside Director
Ezzat Jallad - Outside Director
Jerry L. Burdick - Executive Vice President, Chief Financial Officer,
Secretary and a Director of SeraCare, Inc.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SERACARE, INC.
Date: January 15, 1998 By: /S/
--------------------- -----------------------------
Barry D. Plost
Chairman of the Board, President
and Chief Executive Officer
By: /S/
-------------------------------
Jerry L. Burdick
Executive Vice President and
Chief Financial Officer
3
